Epicardial adipose tissue, functional status, and invasive exercise hemodynamics in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
Impact of Na+/glucose cotransporter 2 (SGLT2) inhibitor therapy on biventricular ventricular-arterial coupling in patients with heart failure with reduced ejection fraction